Illumina reports strong 2Q results; raises outlook

DNA sequencing company Illumina repoted 2Q results which came in above Street expectations. The California-based company said that interest in the NovaSeq platform, launched in January, with the expectation that it could one day lower the cost of sequencing a human genome to $100 helped Illumina to report strong results and raise outlook for 2017. Check out the earnings snapshot: http://alphastreet.com/b3af2cd8